Lumen Marketing Company Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Lumen Marketing Company Pharmaceutical Export Portfolio Dataset — 2 Products, $1.4M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Lumen Marketing Company — Pharmaceutical Exporter Profile (2026) | 2 Products, $1.4M Trade | TransData Nexus

Lumen Marketing Company

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $1.4M Total Trade · DGFT Verified

Lumen Marketing Company is an Indian pharmaceutical exporter with a total trade value of $1.4M across 2 products in 1 therapeutic categories. Based on 29 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ayurvedic ($950.0K), Extract ($500.0K), .

Lumen Marketing Company — Export Portfolio & Destination Treemap

Lumen Marketing Company pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Lumen Marketing Company? — Company Overview & Market Position

Lumen Marketing Company, established in 2012, is a Chennai-based Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company operates from its headquarters at 2, 2nd Floor, I Cross Street - 2nd Avenue, Ashok Nagar, Chennai 600083, India. As of the latest available data, Lumen Marketing Company employs between 10 to 19 individuals. The company is registered under the Corporate Identification Number (CIN) provided by the Ministry of Corporate Affairs, Government of India. In April 2023, Lumen Marketing Company filed a trademark application for its brand, indicating its commitment to brand protection and market presence. The company's revenue for the fiscal year 2022-2023 is not publicly disclosed. For more information, the company can be contacted through the details provided in the Kompass directory.

What Does Lumen Marketing Company Export? — Product Portfolio Analysis

Top Products by Export Value

1Ayurvedic$950.0K 2Extract

Product Portfolio — Top 2 by Export Value

Lumen Marketing Company exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ayurvedic	Ayurvedic & Herbal Products	$950.0K	19	4.1%	4
2	Extract	Ayurvedic & Herbal Products	$500.0K	10	4.1%	2

Lumen Marketing Company exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $1.4M. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Lumen Marketing Company — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Lumen Marketing Company operates its manufacturing facilities in Chennai, India. The plant specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding the plant's production capacity and certifications are not publicly available. The company emphasizes quality control and compliance with industry standards to ensure the safety and efficacy of its products.

3Key Leadership

The leadership team of Lumen Marketing Company includes Mr. S. Selvam, who serves as a Partner. Specific details regarding other key executives, such as the CEO, CFO, and their respective roles, are not publicly disclosed. The company's leadership is committed to maintaining high standards in pharmaceutical manufacturing and export operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Lumen Marketing Company Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Lumen Marketing Company exports its pharmaceutical products to various international markets, including Malaysia. In 2022, the company shipped 200 kilograms of POPCEE Vitamin C 500mg Chewable Tablets to Alpha Bio Medics Sdn Bhd in Malaysia. Specific details regarding regulatory filings, approvals, and market access status in the United States, European Union, United Kingdom, Australia, and Japan are not publicly available. The company is likely working to meet the regulatory requirements of these markets to expand its global footprint.

2Emerging Markets

Lumen Marketing Company has made inroads into emerging markets, notably in Southeast Asia, with exports to Malaysia. The company's focus on Ayurvedic and herbal products aligns with the growing demand for traditional medicine in these regions. While specific details regarding WHO prequalification are not available, the company's commitment to quality suggests efforts to meet international standards, potentially facilitating access to other emerging markets in Africa and Latin America.

3Geographic Strategy

Lumen Marketing Company's export strategy appears to be concentrated in select international markets, with a notable presence in Malaysia. This focused approach may help the company manage resources effectively and build strong relationships in these regions. However, the lack of diversification into multiple markets could expose the company to risks associated with over-reliance on a limited number of markets. Strategic expansion into additional regions could mitigate this concentration risk and support sustainable growth.

Lumen Marketing Company — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Lumen Marketing Company's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. The company's focus on Ayurvedic and herbal products may present challenges in obtaining FDA approvals, as these products often require extensive documentation to demonstrate safety and efficacy. Engaging with regulatory consultants and investing in research and development could enhance the company's prospects in obtaining FDA approvals.

2WHO & EU GMP

Details regarding Lumen Marketing Company's WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly disclosed. Achieving WHO prequalification and EU GMP certification would be significant milestones, enhancing the company's credibility and facilitating access to international markets. The company's commitment to quality suggests ongoing efforts to meet these standards.

3CDSCO & Indian Regulatory

Lumen Marketing Company — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Lumen Marketing Company operates in a competitive landscape with several key players in the Indian pharmaceutical export sector. Companies such as Lumen Pharmachem Private Limited, established in 2015, offer a range of pharmaceutical raw materials and formulations. While Lumen Pharmachem focuses on raw materials, Lumen Marketing Company's emphasis on finished pharmaceutical formulations differentiates its product offerings. The market is characterized by a mix of companies specializing in raw materials and those focusing on finished products, each catering to different segments of the pharmaceutical supply chain.

2Key Differentiators

Lumen Marketing Company's focus on Ayurvedic and herbal products positions it uniquely in the market, catering to the growing global demand for traditional medicine. The company's commitment to quality and compliance with regulatory standards enhances its reputation among international clients. Additionally, the company's strategic location in Chennai, a hub for pharmaceutical manufacturing in India, provides logistical advantages for export operations.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Lumen Marketing Company as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Lumen Marketing Company has demonstrated a consistent track record in exporting pharmaceutical products, with 29 shipments valued at $1.4 million USD between 2022 and 2026. The company's portfolio is concentrated, with its top two products—Ayurvedic and Extract formulations—accounting for 100% of its export value. This concentration indicates a focused product strategy but also suggests potential risks associated with market fluctuations affecting these specific products. The company's adherence to regulatory standards and commitment to quality further enhance its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the company's facility registration with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure the company holds Good Manufacturing Practice certification from the World Health Organization.

Frequently Asked Questions — Lumen Marketing Company

How many pharmaceutical products does Lumen Marketing Company export from India?

Lumen Marketing Company exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Ayurvedic ($950.0K), Extract ($500.0K). Total export value is $1.4M.

What is Lumen Marketing Company's total pharmaceutical export value?

Lumen Marketing Company's total pharmaceutical export value is $1.4M, based on 29 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Lumen Marketing Company cover?

Lumen Marketing Company exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Lumen Marketing Company Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.